Consensus R&G PharmaStudies Co., Ltd.

Equities

301333

CNE100005K44

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-16 EDT			5-day change	1st Jan Change
43.77 ^CNY	-0.93%		-6.33%	-32.12%

04-21	R&G PharmaStudies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	R&G PharmaStudies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Evolution of the average Target Price on R&G PharmaStudies Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

2191976a7e9407042deeb7e41e.2cRJVgDCftHbdSmSrao0TVuO4EgsbdEv4rL-o4uChrc.gZQaDk2uDaOQDFjI1MdFDBjFsQpPOKQett_K8cOwy9iMryoASI4Y5eolXg~ea2bd1571f9707d00414499a3b77116f

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

43.77 CNY

Average target price

60.5 CNY

Spread / Average Target

+38.22%

High Price Target

65 CNY

Spread / Highest target

+48.50%

Low Price Target

56 CNY

Spread / Lowest Target

+27.94%

Consensus detail

Consensus revision (last 18 months)

Ratings for R&G PharmaStudies Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar